Drug abuse headache: Recognition and management

Cephalalgia, Supplement

Volumn 18, Issue SUPPL. 22, 1998, Pages 47-55

  Antonaci, Fabio ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPHENOL; AMITRIPTYLINE; ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CODEINE; DEXAMETHASONE; ERGOTAMINE; HYPNOTIC AGENT; INDOMETACIN; NAPROXEN; NARCOTIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PARACETAMOL; PYRAZOLONE DERIVATIVE; SALICYLIC ACID DERIVATIVE; SEDATIVE AGENT; SUMATRIPTAN; TRANQUILIZER; VALPROIC ACID; VENLAFAXINE;

ANALGESIC AGENT ABUSE; ASTHENIA; CHRONIC DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DEPRESSION; DETOXIFICATION; DRUG OVERDOSE; DRUG WITHDRAWAL; ELECTROSTIMULATION THERAPY; EPIDEMIC; HEADACHE; HEALTH CARE COST; HUMAN; IRRITABILITY; RESTLESSNESS; SUBSTANCE ABUSE;

DISEASE OUTBREAKS; HEADACHE; HUMANS; INCIDENCE; ITALY; META-ANALYSIS; PREVALENCE; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0031713991     PISSN: 08001952     EISSN: None     Source Type: Journal    
DOI: 10.1177/0333102498018s2209     Document Type: Article

References (43)

1. Edmeads J. Analgesic-induced headaches: an unrecognised epidemic. Headache 1990:614-5
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-93
3. Diesen J, Rasmussen BK. The International Headache Society classification of chronic daily and near daily headache: a critique of the criticism. Cephalalgia 1996;16:407-11
4. Diagnostic and statistical manual of mental disorders, DSM-IV-TM. 4th ed. Washington DC. American Psychiatric Association, 1994:1-886
5. Andersson PG. Ergotism - the clinical picture. In: Diener HC, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988:16-9
6. Baumgartner C, Wessely P, Bingöl C, Maly J, Holzner F. Long-term prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989;29:510-4
7. Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinico-epidemiological study. Cephalalgia 1987;7:15-9
8. Micieli G, Manzoni GC, Granella F, Martignoni E, Malferrari G, Nappi G. Clinical and epidemiological observations on drug abuse in headache patients. In: Diener HC, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988:20-8
9. Diener HC, Tfelt-Hansen P. Headache associated with chronic use of substance. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press, 1993:721-7
10. Schwarz A, Faber U, Giaeske G, et al. Daten zu analgetikakonsum und analgetika-nephropathie in der Bundesrepublik. Offentliches gesundheilswesen 1985;47:298-300
11. Gutzwiller F, Zemp E. Der analgetikakonsum in der Bevölkerung und sozioökonomische Aspekte des Analgetikaabusus. In: Mihatsch MJ, editor. Das analgetikasyndrom. Stuttgart: Thieme, 1986:197-205
12. ISTAT report on drug consumption in Italy. 1994
13. Steiner TJ, Counturier EGM, Catarci T, Hering R. Social aspects of drug abuse in headache. Funct Neurol 1997;7/ 6:11-4
14. Sances G, Costa A, Nappi G. Economic impact of headache in a neurological department: a survey of a two year use of the DRG-system. Confinia Cephalalgica 1997;6:148-50
15. Sandrini G, Frediani F, Rossi F, Bussone GH, Sternieri E, Nappi G. Economic aspects of drug abuse/misuse in headache patients. Funct Neurol 1992;7/6:17-21
16. Mathew NT, Kurman R, Perez F. Drug induced refractory headache: clinical features and management. Headache 1990;30:634-8
17. Saper JR. Daily chronic headache. Neurol Clin 1990;8:891-901
18. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987;27:102-6
19. Mathew N, Stubis E, Nigan MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982;22:66-8
20. Diener HC, Búhier K-U, Dichgans J, Geiselhart S, Gerber WD, Scholz E. Analgetikainduzierter dauerkopfschmerz. existiert eine kritische dosis? Arzneimitteltherapie 1988;6:156-64
21. Silberstein SD, Silberstein JR. Chronic daily headache: long-term prognosis following inpatients treatment with repetitive IV DHE. Headache 1992;32:439-45
22. Gaist D, Sindrup S, Hallas G, Gram LF. Misuse of sumatriptan. Lancet 1994;244:1090
23. Evers S, Bauer B, Suhr B, Wieser T, Husstedt IW. The epidemiology of sumatriptan abuse. In: Olesen J, Tfelt-Hansen P, editors. Headache treatment: trial methodology and new drugs. Philadelphia: Lippincott-Raven, 1997:149-52
24. De Marinis M, Janiri L, Agnoli A. Headache in the use and withdrawal of opiates and other associated substances of abuse. Headache 1991;31:159-63
25. Isler H. Die behandiung der kopfschmerzen. Schweiz Med Wochenschr 1984;I 14:1174-80
26. Antonaci F, Sances G, Manni R, Buzzi MG. Epileptic seizure during aspirin and caffeine withdrawal in a drug induced headache. Funct Neurol 1996;11:333-7
27. Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991;337:1442-3
28. Pffaffenrath V. Drug induced headache: diagnosis and treatment. Funct Neurol 1992;7/6:23-5
29. Diamond S. Efficacy and safety profile of venlafaxine in chronic headache. Headache Q 1995:212-5
30. Mathew N, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 1991;31:71-4
31. Moore KL. Valproate in the treatment of refractory recurrent headaches: a retrospective analysis of 207 patients. Headache Q 1992;3:323-5
32. Rothrock JF, Kelly NM, Brody ML, Golbeck A. A differential response to treatment with divalproex sodium in patients with intractable headache. Cephalalgia 1994;14:24 -4
33. Bonuccelli U, Nuti A, Lucetti C, Pavese N, D'Agnello G, Muratorio A. Amitriptyline and dexamethasone combined treatment in drug-induced headache. Cephalalgia 1996;16:197-200
34. Robbins L. Daily opioids (methadone) for refractory chronic daily headache. Headache Q 1996:39-41
35. Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989;236:9-14
36. Schnider P, Aull S, Baumgartner C, Marterer A, Wöber C, Zeiler K, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 1996;16:481-5
37. Diener HC, Pfaffenrath V, Soyka D, Gerber W-D. Therapie des medikamenteninduzierten kopfschmerzes. Münch Med Wochenschr 1992;134:159-62
38. Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near daily headaches: proposed revision to the IHS criteria. Headache 1994;34:1-7
39. Bemhart ER, editor. Physicians' desk reference. 50th ed. Oradell NJ: Medical Economics Inc., 1996
40. Merskey H, Bogduk N. Classification of chronic pain. Seattle: IASP Press, 1994
41. Sjaastad O, Antonaci F. Chronic paroxysmal hemicrania (CPH) and hemicrania continua: transition from one stage to another. Headache 1993;33:551-4
42. Manzoni GC, Granella F, Sandrini G, Cavallini A, Zanferrari C, Nappi G. Classification of chronic daily headache by International Headache Society criteria: limits and new proposals. Cephalalgia 1995;15:37-43
43. Antonaci F. What is the role of international societies and what could they do better? Cephalalgia 1997;17 Suppl 17: 25-8